placeholder image
  • Contact Info

Robert Blum Academic, Dentistry

Positions

selected publications

  • academic article

    • Moujaber TEtemadmoghadam DKennedy CJChiew Y-EBalleine RLSaunders CWain GGao BHogg RSrirangan SKan CFereday STraficante NPatch A-MPearson JWaddell NGrimmond SMDobrovic ABowtell DDLHarnett PRDeFazio ABowtell DChenevix-Trench GGreen AWebb PDeFazio AGertig DTraficante NFereday SMoore SHarrap KSadkowsky TPandeya NHung JMalt MAlexander BAshover EBrown SCorrish TGreen LJackman LFerguson KMartin KMartyn ARanieri BMellon ARobertson RVanden Bergh TJones MMackenzie PMaidens JNattress KChiew YEStenlake ASullivan HWhite JJayde VMamers PBowes LGalletta LGiles DHendley JAlsop KBall CYoung CSchmidt TShirley HViduka SBrooks JStuart-Harris RKirsten RRutovitz JClingan PGlasgow AProietto ABraye SOtton GShannon JBonaventura TStewart JBegbie SBell DBaron-Hay SFerrier AGard GNevell DPavialds NValmadre SYoung BCamaris CCrouch REdwards LHacker NMarsden DRobertson GBeale PBeith JCarter JDalrymple CHoughton RRussell PLinks MGrygiel JHill JBrand AByth KJaworski RSharma RHarnett PWain GFriedlander MWard BPapadimos DCrandon ACummings MHorwood KObermair APerrin LWyld DNicklin JDavy MOehler MKHall CDodd THealy TPittman KHenderson DMiller JPierdes JBlomfield PChallis DMcIntosh RParker ABrown BRome RAllen DGrant PHyde SLaurie RRobbie MHealy DJobling TManolitsas TMcNealage JRogers PSusil BSumithran ESimpson LPhillips KRischin DFax SJohnson DLade SLoughrey MO'Callaghan NMurray WWaring PBillson VPyman JNeesham DQuinn MUnderhill CBell RNg LFBlum RGanju VHammond LLeung YMcCartney ABuck MHaviv IPurdie DWhiteman DZeps N. BRAF mutations in low-grade serous ovarian cancer and response to BRAF inhibitionJCO Precision Oncology.  2:1-14. 2018
      Full text if available
    • Kondrashova OTopp MNesic KLieschke EHo G-YHarrell MZapparoli GHadley AHolian RBoehm EHeong VSanij EPearson RBKrais JJJohnson NMcNally OAnanda SAlsop KHutt KJKaufmann SHLin KKHarding TCTraficante NdeFazio AMcNeish LABowtell DDSwisher EMDobrovic AWakefield MJScott CLChenevix-Trench GGreen AWebb PGertig DFereday SMoore SHung JHarrap KSadkowsky TPandeya NMalt MMellon ARobertson RVanden Bergh TJones MMackenzie PMaidens JNattress KChiew YEStenlake ASullivan HAlexander BAshover PBrown SCorrish TGreen LJackman LFerguson KMartin KMartyn ARanieri BWhite JJayde VMamers PBowes LGalletta LGiles DHendley JSchmidt TShirley HBall CYoung CViduka STran HBilic SGlavinas LBrooks JStuart-Harris RKirsten FRutovitz JClingan PGlasgow AProietto ABraye SOtton GShannon JBonaventura TStewart JBegbie SFriedlander MBell DBaron-Hay SFerrier AGard GNevell DPavlakis NValmadre SYoung BCamaris CCrouch REdwards LHacker NMarsden DRobertson GBeale PBeith JCarter JDalrymple CHoughton RRussell PLinks MGrygiel JHill JBrand AByth KJaworski RHarnett PSharma RWain GWard BPapadimos DCrandon ACummings MHorwood KObermair APerrin LWyld DNicklin JDavy MOehler MKHall CDodd THealy TPittman KHenderson DMiller JPierdes JBlomfield PChallis DMclntosh RParker ABrown BRome RAllen DGrant PHyde SLaurie RRobbie MHealy DJobling TManolitsas TMcNealage JRogers PSusil BSumithran ESimpson IPhillips KRischin DFox SJohnson DLade SLoughrey MO'Callaghan NMurray WWaring PBillson VPyman JNeesham DQuinn MUnderhill CBell RNg LFBlum RGanju VHammond ILeung YMcCartney ABuck MHaviv IPurdie DWhiteman DZeps N. Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinomaNature Communications.  9:1-16. 2018
      Full text if available